Article Versions Notes

De La Flor JC, Villa D, Cruzado L, Apaza J, Valga F, Zamora R, Marschall A, Cieza M, Deira J, Rodeles M. Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors? Biomedicines. 2023; 11(7):1908. https://doi.org/10.3390/biomedicines11071908

De La Flor, José C., Daniel Villa, Leónidas Cruzado, Jacqueline Apaza, Francisco Valga, Rocío Zamora, Alexander Marschall, Michael Cieza, Javier Deira, and Miguel Rodeles. 2023. "Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors?" Biomedicines 11, no. 7: 1908. https://doi.org/10.3390/biomedicines11071908

De La Flor, J. C., Villa, D., Cruzado, L., Apaza, J., Valga, F., Zamora, R., Marschall, A., Cieza, M., Deira, J., & Rodeles, M. (2023). Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors? Biomedicines, 11(7), 1908. https://doi.org/10.3390/biomedicines11071908